Characterization of the nasopharyngeal microbiome in patients with Kawasaki disease

An Pediatr (Engl Ed). 2022 Nov;97(5):300-309. doi: 10.1016/j.anpede.2022.08.001. Epub 2022 Oct 11.

Abstract

Introduction: The aetiology of Kawasaki disease (KD) remains unknown. Several studies have linked the human microbiome with some diseases. However, there are limited studies on the role of the respiratory microbiome in KD. The aim of our study was to make a more thorough analysis of the causes and processes that increase the susceptibility to KD.

Methods: Case-control study comparing the respiratory microbiome of KD patients with that of healthy children. The V3-V4 region of the 16S rRNA bacterial gene and 16 respiratory viruses were analysed by real-time polimerase-chain reaction. We used the Ribosomal Database Project (RDP) version 11.5 (taxonomic assignment).

Results: The initial sample included 11 cases and 11 controls matched for age, sex and seasonality. One of the cases was excluded to poor sample quality. The final analysis included 10 cases and 10 controls. In the case group, the analysis detected Haemophilus, Moraxella, Streptococcus and Corynebacterium species (27.62%, 19.71%, 25.28%, 11.86%, respectively). In the control group, it found Haemophilus, Streptococcus, Moraxella, and Dolosigranulum species (38.59%, 23.71%, 16.08, 8.93%, respectively). We found a higher relative abundance of Corynebacterium in patients with KD (11.86% vs. 1.55%; P = 0.004).

Conclusions: To our knowledge, this is the first study that has found differences in the composition of the respiratory microbiome between patients with KD and healthy controls. The relative abundance of Corynebacterium spp. was greater in the KD group. This study shows differences in the microbiome between cases and controls, which suggests that the microbiome may play a role in facilitating the development of KD.

Keywords: Corynebacterium; Kawasaki; Microbioma; Microbioma respiratorio; Microbiome; Respiratory microbiome.

MeSH terms

  • Case-Control Studies
  • Child
  • Corynebacterium / genetics
  • Humans
  • Microbiota* / genetics
  • Mucocutaneous Lymph Node Syndrome*
  • Nasopharynx / chemistry
  • Nasopharynx / microbiology
  • RNA, Ribosomal, 16S / analysis
  • RNA, Ribosomal, 16S / genetics

Substances

  • RNA, Ribosomal, 16S